To investigate expression of SIGLEC1 in different breast cancer subtypes we performed multiplex immunohistochemistry (Tsujikawa et al., 2017) on breast cancer tissues that had been independently acquired from cohort 3. The gene discussed is SIGLEC1; the disease is breast carcinoma.